-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Xylem, Lowers Price Target to $139

Benzinga·10/13/2026 18:05:39
Listen to the news
Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and lowers the price target from $159 to $139.